UK: Daily Coronavirus press conference in 10 Downing Street hosted by Alok Sharma MP, Part Seven.

The transcript discusses the progress of clinical trials for a vaccine, highlighting a licensing agreement between Oxford University and AstraZeneca for vaccine commercialization. It outlines plans to produce 30 million doses for the UK by September, with a total of over 100 million doses. The UK will have priority access, and efforts will be made to provide the vaccine to developing countries at low cost. Additionally, the UK government is accelerating the construction of a vaccine manufacturing innovation center in Oxfordshire.

What is the purpose of the global licensing agreement between Oxford University and Astra Zeneca?

• To develop a new vaccine for a different disease

• To conduct clinical trials in the UK

• To ensure the vaccine is available only in the UK

• To commercialize and manufacture the Oxford vaccine

How many doses of the vaccine does Astra Zeneca plan to make available by September for the UK?

• 10 million

• 30 million

• 100 million

• 50 million

Which country will have the first access to the vaccine according to the agreement?

• India

• Australia

• United States

• United Kingdom

What is the UK government doing to support domestic vaccine manufacturing?

• Importing vaccines from other countries

• Building the UK's first Vaccines Manufacturing Innovation Center

• Partnering with other European countries

• Reducing funding for vaccine research

Where is the UK's first Vaccines Manufacturing Innovation Center being built?

• London

• Cambridge

• Manchester

• Harwell in Oxfordshire